SENIOR TEAM

Jerry Boudreault is the President and Founder of DDR. With over 20 years’ experience in the healthcare industry, Jerry has an impressive track record of successfully bringing biopharmaceutical products to market. Prior to founding DDR, Jerry was Director of Supply Operations at Transkaryotic Therapies, Inc., where he was responsible for managing external manufacturing and distribution capacity for all clinical and commercial biologic products as well as industrializing the operations of TKT in preparation for the launch of Replagal®. Previous to that, he spent 12 years at Biogen, Inc. where he held management positions in the operations planning, Avonex® supply chain, outsourcing and clinical and commercial manufacturing groups. 

​

Jerry graduated magna cum laude with a BS in Operations Management and Economics from the University of Massachusetts, Boston, with distinction in Economics. Jerry is currently serving a 2-year term as President of the New England PDA (Parenteral Drug Association).

Carolyn Green, Ph.D., MBA, has been a Vice President at DDR since 2006. Focusing on Regulatory Affairs, Analytical Development and Project Management, Carolyn brings expertise in development and post-approval activities, business processes for Quality Control groups in data management systems and contract development, and in CMC Regulatory Affairs with filings for NDA, IND, amendments and supplements to the FDA, EU, Canada and other international markets. Prior to DDR, Carolyn held senior scientific positions at Momenta Pharmaceuticals, Inc. and Millennium Pharmaceuticals, Inc., where she gained invaluable experience in GMP facility compliance, authoring regulatory filings, developing and validating analytical characterization methods, collaborating with external analytical laboratories, setting specifications for CMC team for starting materials, intermediates, API and DP, and working with Quality Control to evaluate drug impurities.

​

Carolyn holds a BA in Chemistry from Albion College in Michigan, a Ph.D. in Chemistry from the University of Iowa, Iowa City, and an MBA from the University of Massachusetts, Boston

Patrick earned his Bachelor’s degree from the University of Colorado, Boulder, and shortly after began his career with a customs brokerage firm, hand-carrying U.S. entries for Northrop to the LAX customs office. He then moved to San Francisco, where he worked across Transpacific, Latin American, and European shipping lanes in operations, pricing, and sales for global steamship lines—all while earning a Master's degree in Transportation from Golden Gate University.

​

His transition into the pharmaceutical trade led him to obtain his U.S. Customs Broker License, and over the past 12 years, he has played integral roles in logistics and global trade compliance at Pharmacyclics, Portola Pharmaceuticals, Esperion Therapeutics and other biotech companies through his own consultancy, Pillsbury Logistics and Trade, LLC.

​

​

​

​

​